Weekly Funding Opps

Foundation

• Alex's Lemonade Stand
  Early Career Research Programs
• Gray Foundation
  GRAY FOUNDATION BRCA TEAM SCIENCE PROGRAM
• Prostate Cancer Foundation
  Prostate Cancer Foundation Awards (Various)
  Deadlines vary across grants
• Lung Cancer research Foundation (LCRF)
  LCRF (various)
• Memorial Sloan Kettering Cancer Center
  Clinical Chemistry Fellowship
  Applications will be accepted until the position is filled. Early application is encouraged.
• American Association for Cancer Research (AACR)
  AACR MINORITY SCHOLAR IN CANCER RESEARCH AWARDS
• St. Baldrick's Foundation
  St. Baldrick's Foundation Spring Grant Cycle
  Deadlines vary across awards
• American Cancer Society
  American Cancer Society Grants (various)
  Deadlines April 1 and October 15
• Melanoma Research Foundation
  Melanoma Research Foundation RFP (various)
  Due dates vary by grant
• Alan B. Slifka Foundation
  Sarcoma Research Grants Initiative
  send a 1-2 page letter of intent (LOI) to sarcomaLOI@slifkafoundation.org.
• Pew
  Pew-Stewart Scholars for Cancer Research
• Society for Immunology of Cancer
  2024 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship
• Colorectal Cancer Alliance
  Project Cure CRC
  rolling request for proposals
• OREF
  OREF Research Grants (various)
• Union for International Cancer Control UICC
  Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
  opens autumn 2023
• The Hope Foundation
  SWOG Trial Support (STrS)
• American Lung Association
  American Lung Association (various)
  due dates vary -- see application for each award
• Society for Immunology of Cancer
  SITC-Merck Cancer Immunotherapy Clinical Fellowship
• Robert A. Winn Diversity in Clinical Trials Award Program
  Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA)
• Cholangiocarcinoma Foundation
  Cholangiocarcinoma Foundation Research Fellowship Program
  LOI due: 08/11/2023
• Melanoma Research Alliance
  Melanoma Research Alliance RFP
  LOI due: 09/20/2023
• Cancer Prevention Initiative
  CPI 2023-24 Research Grants – Request for Proposals
  LOI due: 10/15/2023
• The Mark Foundation
  Endeavor Award
  LOI due: 03/12/2024
• The Mark Foundation
  The Mark Foundation Emerging Leader Award
  LOI due: 04/29/2024
• Sarcoma Foundation of America
  Sarcoma Research Grants
  Application Due: 02/03/25
• American Psychological Foundation
  Alice F. Chang Cancer Wellness Grant
  Application Due: 02/07/25
• American Association for Cancer Research (AACR)
  AACR-KIDNEYCAN KIDNEY CANCER INNOVATION AND DISCOVERY GRANT
  Application Due: 02/18/25
• B*CURED
  B*CURED Research Grant
  Application Due: 03/03/25

Internal

• UMGCCC
  Student/trainee supplements for PIO faculty to mentor undergraduate or high school trainees
  $1,200/trainee to offset expenses (e.g. supplies, stipends)
• FDA
  FDA OWH/CERSI Funding Opportunity
  Please direct any questions and submit one-page proposals to Dr. Joyce Obidi (Joyce.Obidi@fda.hhs.gov) and cc to ORSI-CERSI-Team@fda.hhs.gov by September 8, 2023.
• UMGCCC
  UMGCCC research mentors for teachers in NCI CATALYST (CURE) program
  please contact Bret Hassel if interested (bhassel@som.umaryland.edu)
• NIH
  Administrative Supplement Funding Opportunities
  If interested in applying, please send Sarah Laye a 1-page abstract and NIH biosketches of key personnel by Friday, 3/15/24.
• UMB SOM
  The University of Maryland Claude D. Pepper Older Americans Independence Center
  LOI due: 10/30/2023
• UMSOM
  Large Grant Acceleration Program (LGAP)
• V Foundation
  Future V Foundation Opportunities
  contact Sarah Laye for more information at slaye@som.umaryland.edu
• US Department of Veteran Affairs (VA)
  VA opportunities

  If interested in obtaining the PDF version of a particular VA opportunity and to inquire on eligibility, please email Natalie Dugger (Natalie.Dugger@va.gov) and cc Sarah Laye (slaye@som.umaryland.edu) on your request. Note that VA opportunities are specific and you must confirm eligibility with the VA.

  Deadline varies by grant

MDH

• Maryland Department of Health
  MHHD Grant Programs
  see each grant for specific deadline

• Society for Immunotherapy of Cancer
  SITC-MRA Women in Melanoma Fellowship Award

Prize

• Pershing Square Foundation
  MIND Prize
  LOI due: 11/13/2023
• National Foundation for Cancer Research
  Szent-Györgyi Prize for Progress in Cancer Research
  Application Due: 02/28/25

NIH

• NIH
  The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
  Standard due dates apply
• NCI
  NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
  no LOI required
  Standard due dates apply
• NCI
  NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed)
  Standard due dates apply
• NCI
  Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
  Standard due dates apply
• NCI
  Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
  Standard due dates apply
• NIH
  Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
  Standard due dates apply
• NIH
  Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
  Standard due dates apply
• NIH
  Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
  LOI due 30 days before application due date
  Standard due dates apply
• NCI
  Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
  LOI due 30 days before application due date
  Standard due dates apply
• NIH
  Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
  Standard due dates apply
• NIH
  P30 Administrative Supplements NOFOs (various)
  please send 1 page abstract and NIH biosketch to Sarah Laye if interested. One application per NOFO.
• NCI
  Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required)
  Standard due dates apply
• NCI
  National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
  LOI due 30 days before application due date
  Standard due dates apply
• NCI
  Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
  Applications are accepted by continuous receipt.
• NCI
  Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
  Standard due dates apply
• NCI
  Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
  Standard due dates apply
• NCI
  Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
  Standard due dates apply
• NIH
  HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
  Standard due dates apply
• NCI
  Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
  Standard due dates apply
• NCI
  Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)
  Standard due dates apply
• NCI
  Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
  Standard due dates apply
• NIH
  PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
  Standard due dates apply
• NCI
  Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required)
  Standard due dates apply
• NIH
  Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
  Standard due dates apply
• NCI
  Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
  Standard due dates apply
• NCI
  Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
  Application Due: 01/08/25
• NCI
  Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
  LOI due: 01/04/2025
  Application Due: 02/04/25
• NCI
  The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
  Application Due: 02/19/25
  Standard due dates apply
• NIH
  Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required)
  LOI due: 01/19/2025
  Application Due: 02/19/25
• NCI
  Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)
  Application Due: 03/02/25
• NCI
  Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
  Standard due dates apply

NIH NOSI

• NIH
  Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research
  Application Due: 12/31/24
• NCI
  Notice of Special Interest (NOSI): Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program
  Application Due: 01/08/25
• NIH
  Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
  Application Due: 05/01/25
• NCI
  Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
  Application Due: 05/01/25
• NIH
  Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
  Application Due: 05/01/25
• NCI
  Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
  Application Due: 05/01/25
• NCI
  Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
  Application Due: 05/01/25
• NIH
  Notice of Special Interest (NOSI): Adaptive Biomaterials for Cancer Biology
  Application Due: 05/07/25
• NCI
  Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials
  Application Due: 07/01/25
• NIH
  Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
  Application Due: 07/02/25
• NCI
  Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
  Application Due: 07/02/25
• NIH
  Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
  Application Due: 07/02/25
• NCI
  Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
  Application Due: 07/02/25
• NCI
  Notice of Special Interest: Health Influences of Gender as a Social and Structural Variable
  Application Due: 10/01/25
• NCI
  Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings
  Application Due: 11/18/25
• NCI
  Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings
  Application Due: 11/18/25
• NIH
  Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
  Application Due: 01/08/26
• NCI
  Notice of Special Interest (NOSI): Telehealth Research in Cancer Care
  Application Due: 03/17/26
• NCI
  Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk
  Application Due: 05/09/26
• NCI
  Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk
  Application Due: 05/09/26
• NIH
  Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions
  Application Due: 06/06/26
• NIH
  Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities
  Application Due: 06/06/26
• NIH
  Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations
  Application Due: 06/06/26
• NCI
  Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
  Application Due: 09/08/26
• NCI
  Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities
  Application Due: 10/10/26
• NCI
  Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities
  Application Due: 10/10/26
• NCI
  Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe)
  Application Due: 11/17/26
• NIAID
  Notice of Special Interest (NOSI): Development of Organotypic Culture Models for Transplantation Immunology Research
  Application Due: 11/17/26
• NCI
  Notice of Special Interest (NOSI): National Cancer Institute Entrepreneurial Education Programs to Facilitate Commercialization of Cancer Relevant Technologies
  Application Due: 01/08/27
• NCI
  Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications
  Application Due: 01/27/27
• NCI
  Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease
  Application Due: 05/10/27
• NIH
  Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health
  Application Due: 07/14/27
• NCI
  Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research
  Application Due: 07/31/27
• NCI
  Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being
  Application Due: 11/14/27
• NCI
  Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences
  Application Due: 05/08/29
• NCI
  Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention
  Application Due: 05/08/29
• NCI
  Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention
  Application Due: 05/08/29
• NCI
  Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences
  Application Due: 05/08/29

DOD

• DOD
  FY23 DoD Melanoma Grants
  Deadlines vary across awards
• DOD
  DOD 2023 Breast Cancer Research Program (BCRP)
• DOD
  FY23 Ovarian Cancer Research Program (OCRP) (various)
  Deadlines vary across awards

COVID

• UM VENTURES
  UMCP / UMB Coronavirus Medical Device Challenge Program
  Applications will be accepted on a rolling basis through May 2020 (or until funds are exhausted); funding decisions will be made bi-weekly until all funds are spent.
• University of Maryland Baltimore, Institute for Clinical & Translational Research (UMB ICTR)
  Special Call for COVID-19 ICTR Voucher Applications
  Applications will be accepted on a rolling basis.
• NIH
  Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
  Expiration Date: 9/8/24.
• UMB SOM Office of Research Career Development
  Funding for Research on COVID-19 and Information for NIH Applicants re: Impact of COVID-19 on Grants and Submissions